Eugenol-Functionalized Bovine Bone Substitutes for Potential Osteogenic Applications

Abstract The study explored the role of eugenol-functionalized bovine bone substitutes in mitigating oxidative stress and promoting osteogenesis in vitro. Bovine bones were subjected to decellularization employing physicochemical and enzymatic procedures to prepare decellularized bovine bone scaffolds (DCC). Eugenol-chitosan functionalized DCC (ECF-DCC) bone substitutes were fabricated by ball-milling DCC scaffolds, spray-drying eugenol-chitosan particulates, integrating β-TCP, and lyophilizing the homogenized composites. ECF-DCC were comprehensively assessed by SEM-EDS, RAMAN spectroscopy, and osteoblast-based viability, apoptosis, reactive oxygen species (ROS) generation, osteogenic differentiation [alkaline phosphatase (ALP), mineralization], real-time PCR, and Western blotting. RAMAN spectroscopy confirmed successful eugenol functionalization of DCC substitutes, evidenced by characteristic aromatic C═C and C–O vibrational peaks alongside preserved phosphate signatures. SEM–EDS revealed rough substitutes in 500–750 μm size with comparable elemental profiles. hFOB 1.19 cells were viable across all concentrations, with no significant increase in apoptosis, although a low-level necrosis was observed at 1000 μg/mL. ECF-DCC significantly reduced ROS generation compared to DCC. Gene expression analysis showed that ECF-DCC markedly reduced key proinflammatory cytokines including IL-6, IL-1β, and TNF-α. Both formulations enhanced osteogenic differentiation, with ECF-DCC inducing superior upregulation of RUNX2, OC, Col1, and BMP-7 at mRNA and protein levels. ECF-DCC substitutes also showed highest ALP activity and calcium mineralization, confirming their enhanced osteoinductive potential. Eugenol-chitosan functionalization enhanced the biological performance of DCC substitutes by reducing oxidative stress and inflammatory responses while significantly promoting osteogenic differentiation, highlighting potential use as improved osteoinductive bone substitutes.

Authors

Institutions

Publication Details

Journal
ACS Omega
Published
2026-09-30
DOI
https://doi.org/10.1021/acsomega.6c06432
Primary Topic
Bone Tissue Engineering Materials
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Eugenol-Functionalized Bovine Bone Substitutes for Potential Osteogenic Applications

Natarajan Chandrasekaran, Ali Al Qabbani, Aghila Rani Koippallil Gopalakrishnan, Savitha Suresh et al.
ACS Omega
Bone Tissue Engineering Materials
article

Eugenol-Functionalized Bovine Bone Substitutes for Potential Osteogenic Applications

Natarajan Chandrasekaran, Ali Al Qabbani, Aghila Rani Koippallil Gopalakrishnan, Savitha Suresh, Ab Rani Samsudin, Vellore Kannan Gopinath, Sausan Al Kawas
article en

Abstract

Abstract The study explored the role of eugenol-functionalized bovine bone substitutes in mitigating oxidative stress and promoting osteogenesis in vitro. Bovine bones were subjected to decellularization employing physicochemical and enzymatic procedures to prepare decellularized bovine bone scaffolds (DCC). Eugenol-chitosan functionalized DCC (ECF-DCC) bone substitutes were fabricated by ball-milling DCC scaffolds, spray-drying eugenol-chitosan particulates, integrating β-TCP, and lyophilizing the homogenized composites. ECF-DCC were comprehensively assessed by SEM-EDS, RAMAN spectroscopy, and osteoblast-based viability, apoptosis, reactive oxygen species (ROS) generation, osteogenic differentiation [alkaline phosphatase (ALP), mineralization], real-time PCR, and Western blotting. RAMAN spectroscopy confirmed successful eugenol functionalization of DCC substitutes, evidenced by characteristic aromatic C═C and C–O vibrational peaks alongside preserved phosphate signatures. SEM–EDS revealed rough substitutes in 500–750 μm size with comparable elemental profiles. hFOB 1.19 cells were viable across all concentrations, with no significant increase in apoptosis, although a low-level necrosis was observed at 1000 μg/mL. ECF-DCC significantly reduced ROS generation compared to DCC. Gene expression analysis showed that ECF-DCC markedly reduced key proinflammatory cytokines including IL-6, IL-1β, and TNF-α. Both formulations enhanced osteogenic differentiation, with ECF-DCC inducing superior upregulation of RUNX2, OC, Col1, and BMP-7 at mRNA and protein levels. ECF-DCC substitutes also showed highest ALP activity and calcium mineralization, confirming their enhanced osteoinductive potential. Eugenol-chitosan functionalization enhanced the biological performance of DCC substitutes by reducing oxidative stress and inflammatory responses while significantly promoting osteogenic differentiation, highlighting potential use as improved osteoinductive bone substitutes.

ACS Omega
University of Sharjah (AE), Vellore Institute of Technology University (IN)
Openalex Percentile: Top 22%
Bone Tissue Engineering Materials
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.